Washington, DC 4/28/15—OpGen has announced in a filing with the SEC that it plans to complete its IPO at a price of $5.50–$6.50 per share (see IBO 3/15/15). The company expects to offer 2.5 million shares. At a share price of $6.00, the offering would raise $12.8 million or $14.8 million if underwriters exercise their options. OpGen disclosed that it plans to negotiate with Fluidigm to distribute Fluidigm chips as part of its Acuitas test kit, which will run on Fluidigm systems.